Project: A non-invasive treatment to protect visual function in early stage diabetic retinopathy patients

Acronym PREVIN (Reference Number: 11008)
Duration 01/04/2017
Project Topic PREVIN combines a novel drug delivery method to treat patients with Diabetic Retinopathy (DR) (i.e. blindness in Diabetes patients) with established drugs. This method will improve localized drug delivery with cyclodextrin nanoparticles to the back of the eye for effective, safe, low-cost, preventive and non-invasive treatment of DR. PREVIN, supported by extensive safety and efficacy studies, will be ready for licensing within one year after the end of the project.
Network Eurostars 2
Call Eurostars Cut-Off 6

Project partner

Number Name Role Country
1 Oculis Pharma Coordinator Iceland
2 Experimentica Ltd Partner Finland
3 Nucro-Technics, a Division of the Vimy Ridge Group Ltd. Partner Canada
4 Medical University of Vienna Partner Austria
5 University of Copenhagen, Zealand University Hospital Partner Denmark